<DOC>
	<DOCNO>NCT02105012</DOCNO>
	<brief_summary>This randomize , double-blind , chronic dosing ( 4 week ) , four-period , five-treatment , incomplete block , cross-over , multicenter study assess efficacy safety four dos budesonide inhalation aerosol ( BD MDI , PT008 ) relative placebo MDI adult subject mild moderate persistent asthma .</brief_summary>
	<brief_title>Chronic Dosing , Cross-Over Study Assess Efficacy Safety Budesonide ( PT008 ) Adult Subjects With Mild Moderate Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>≥ 18 65 year age Diagnosis mild moderate persistent asthma , diagnose least 6 month prior screen Currently receive treatment low medium dose inhale corticosteroid ( ICS ) OR combination controller medication least 4 week precede screen Prealbuterol FEV1 &gt; 60 % &lt; 85 % predict normal value Reversibility : Increase FEV1 ≥ 12 % ≥ 200 mL prealbuterol FEV1 within 30 60 minute inhalation 4 puff Ventolin hydrofluoroalkane ( HFA ) Asthma Symptom Criteria : Have require albuterol use least two last seven day Asthma Control Questionnaire ( ACQ ) total score ≥ 1.5 prior Randomization LifeThreatening Asthma : A subject must lifethreatening asthma define history significant asthma episode ( ) require intubation associate hypercapnia , respiratory arrest , hypoxic seizure , asthmarelated syncopal episode ( ) within 12 month prior screen Worsening Asthma : A subject must experience worsen asthma involve emergency department visit , hospitalization use oral/parenteral corticosteroid within 6 week screen Intermittent , Seasonal , ExerciseInduced Asthma Alone : Subjects intermittent , seasonal exerciseinduced asthma exclude participation study Concurrent Respiratory Disease Pregnant woman nurse mother A current diagnosis Chronic Obstructive Pulmonary Disease ( COPD Current smoker subject &gt; 10 pack year history cigarette , cigar , pipe smoke Respiratory tract infection within 6 week prior Visit 1 Subjects document myocardial infarction within year screen visit Clinically significant abnormal ECG Abnormal liver function test define aspartate aminotransferase ( AST ) , alanine aminotransferace ( ALT ) , alkaline phosphatase total bilirubin ≥ 1.5 time upper limit normal repeat test Subjects cancer complete remission least 5 year Drug Allergy : Subjects history hypersensitivity component metereddose inhaler ( MDI )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Mild</keyword>
	<keyword>moderate persistent</keyword>
	<keyword>Adult</keyword>
</DOC>